Diphenhydramine

From Wikipedia, the free encyclopedia
  (Redirected from Unisom)
Jump to: navigation, search
Diphenhydramine
Diphenhydramine 2D skeletal.svg
Diphenhydramine 3D ball.png
Systematic (IUPAC) name
2-(diphenylmethoxy)-N,N-dimethylethanamine
Clinical data
Pronunciation /ˌdfɛnˈhdrəmn/
Trade names Benadryl, Unisom, Sominex, ZzzQuil
AHFS/Drugs.com Monograph
MedlinePlus a682539
Pregnancy
category
  • AU: A
  • US: B (No risk in non-human studies)
Dependence
liability
Very low
Routes of
administration
Oral, IM, IV, topical and suppository
Legal status
Legal status
Pharmacokinetic data
Bioavailability 40–60%[1]
Protein binding 98–99%
Metabolism Various cytochrome P450 liver enzymes: CYP2D6 (80%), 3A4 (10%)[2]
Biological half-life 7 hours (children)[3]
12 hours (adults)[3]
17 hours (elderly)[3]
Excretion 94% through the urine, 6% through feces[4]
Identifiers
CAS Number 58-73-1 YesY
ATC code D04AA32 (WHO) D04AA33 (WHO), R06AA02 (WHO)
PubChem CID 3100
IUPHAR/BPS 1224
DrugBank DB01075 YesY
ChemSpider 2989 YesY
UNII 8GTS82S83M YesY
KEGG D00669 N
ChEBI CHEBI:4636 YesY
ChEMBL CHEMBL657 YesY
Chemical data
Formula C17H21NO
Molar mass 255.355 g/mol
 NYesY (what is this?)  (verify)

Diphenhydramine (DPH, DHM) is a first-generation antihistamine mainly used to treat allergies. It is also used in the management of drug-induced parkinsonism and other extrapyramidal symptoms. The medication has a sedating effect and is FDA-approved as a nonprescription sleep aid. It possesses anticholinergic, antitussive, antiemetic, and sedative properties.

Diphenhydramine was first synthesized by George Rieveschl and first made publicly available through prescription in 1946.[5] Diphenhydramine is marketed under the trade name Benadryl by McNeil Consumer Healthcare in the U.S., Canada, and South Africa (trade names in other countries include Dimedrol, Daedalon, and Nytol). It is also available as a generic medication.

Medical uses[edit]

Diphenhydramine is a first-generation antihistamine used to treat a number of conditions including allergic symptoms and itchiness, the common cold, insomnia, motion sickness, and extrapyramidal symptoms.[6][7] Diphenhydramine also has local anesthetic properties, and has been used as such in people allergic to common local anesthetics such as lidocaine.[8]

Allergies[edit]

Diphenhydramine is effective in treatment of allergies.[9] As of 2007 it was the most commonly used antihistamine for acute allergic reactions in the emergency department.[10]

By injection it is often used in addition to epinephrine for anaphylaxis.[11] As of 2007 its use for this purpose has not been properly studied.[12] And its use is only recommended once acute symptoms have improved.[9]

Also, topical formulations of diphenhydramine are available, including creams, lotions, gels, and sprays. These are used to relieve itching, and have the advantage of causing fewer systemic effects (e.g., drowsiness) than oral forms.[13]

Movement disorders[edit]

Diphenhydramine is used to treat Parkinson's disease-like extrapyramidal symptoms caused by antipsychotics.[14]

Sleep[edit]

Because of its sedative properties, diphenhydramine is widely used in nonprescription sleep aids for insomnia. The drug is an ingredient in several products sold as sleep aids, either alone or in combination with other ingredients such as acetaminophen (paracetamol). An example of the latter is Tylenol PM. Diphenhydramine can cause minor psychological dependence.[15] Diphenhydramine can cause sedation and has also been used as an anxiolytic.[16]

Nausea[edit]

Diphenhydramine also has antiemetic properties, which make it useful in treating the nausea that occurs in vertigo and motion sickness.[17]

Adverse effects[edit]

The most prominent side effect is sedation. A typical dose creates driving impairment equivalent to a blood-alcohol level of 0.1 which is higher than the 0.08 limit of most drunk driving laws.[10]

Diphenhydramine is a potent anticholinergic agent. This activity is responsible for the side effects of dry mouth and throat, increased heart rate, pupil dilation, urinary retention, constipation, and, at high doses, hallucinations or delirium. Other side effects include motor impairment (ataxia), flushed skin, blurred vision at nearpoint owing to lack of accommodation (cycloplegia), abnormal sensitivity to bright light (photophobia), sedation, difficulty concentrating, short-term memory loss, visual disturbances, irregular breathing, dizziness, irritability, itchy skin, confusion, increased body temperature (in general, in the hands and/or feet), temporary erectile dysfunction, and excitability, and although it can be used to treat nausea, higher doses may cause vomiting.[18] Some side effects, such as twitching, may be delayed until the drowsiness begins to cease and the person is in more of an awakening mode. It has been implicated in the occasional development of restless leg syndrome.[19]

Torsades de pointes can occur as a side effect of diphenhydramine

Acute poisoning can be fatal, leading to cardiovascular collapse and death in 2–18 hours, and in general is treated using a symptomatic and supportive approach.[20] Diagnosis of toxicity is based on history and clinical presentation, and in general specific levels are not useful.[21] Several levels of evidence strongly indicate diphenhydramine (similar to chlorpheniramine) can block the delayed rectifier potassium channel and, as a consequence, prolong the QT interval, leading to cardiac arrhythmias such as torsades de pointes.[22] No specific antidote for diphenhydramine toxicity is known, but the anticholinergic syndrome has been treated with physostigmine for severe delirium or tachycardia.[21] Benzodiazepines may be administered to decrease the likelihood of psychosis, agitation, and seizures in patients who are prone to these symptoms.[23]

Some patients have an allergic reaction to diphenhydramine in the form of hives.[24][25] However, restlessness or akathisia can also be a side effect made worse by increased levels of diphenhydramine, especially with recreational dosages.[26] As diphenhydramine is extensively metabolized by the liver, caution should be exercised when giving the drug to individuals with hepatic impairment.

Long term anticholinergic use is associated with an increased risk for cognitive decline and dementia among older people.[27]

Special populations[edit]

Diphenhydramine is not recommended for patients older than 60 or children under the age of six, unless a physician is consulted.[28] These populations should be treated with second-generation antihistamines such as loratadine, desloratadine, fexofenadine, cetirizine, levocetirizine, and azelastine.[20] Due to its strong anticholinergic effects, diphenhydramine is on the "Beers list" of drugs to avoid in the elderly.[29][30]

Diphenhydramine is category B in the FDA Classification of Drug Safety During Pregnancy.[31] It is also excreted in breast milk.[32] Paradoxical reactions to diphenhydramine have been documented, in particular among children, and it may cause excitation instead of sedation.[26]

Topical diphenhydramine is sometimes used especially on patients in hospice. This use is without indication and topical diphenhydramine should not be used as treatment for nausea because research does not indicate this therapy is more effective than alternatives.[33]

Measurement in body fluids[edit]

Diphenhydramine can be quantified in blood, plasma, or serum.[34] Gas chromatography with mass spectrometry (GC-MS) can be used with electron ionization on full scan mode as a screening test. GC-MS or GC-NDP can be used for quantification.[34] Rapid urine drug screens using immunoassays based on the principle of competitive binding may show false-positive methadone results for patients having ingested diphenhydramine.[35] Quantification can be used to monitor therapy, confirm a diagnosis of poisoning in hospitalized patients, provide evidence in an impaired driving arrest, or assist in a death investigation.[34]

Mechanism of action[edit]

Overview of diphenhydramine targets and effects
Biological target Mode of action Effect
H1 receptor
(Peripheral)
Inverse agonist Allergy reduction
H1 receptor
(Central)
Inverse agonist Sedation
mAChR Receptors Competitive antagonist Anticholinergic
Antiparkinson
Na channel Blocker Local anesthetic
SERT Inhibitor Mood alteration

Diphenhydramine is an inverse agonist of the histamine H1 receptor.[36] It is a member of the ethanolamine class of antihistaminergic agents.[20] By reversing the effects of histamine on the capillaries, it can reduce the intensity of allergic symptoms. It also crosses the blood–brain barrier and inversely agonizes the H1 receptors centrally.[36] Its effects on central H1 receptors cause drowsiness.

Like many other first-generation antihistamines, diphenhydramine is also a potent antimuscarinic (a competitive antagonist of muscarinic acetylcholine receptors) and, as such, at high doses can cause anticholinergic syndrome.[37] The utility of diphenhydramine as an antiparkinson agent is the result of its blocking properties on the muscarinic acetylcholine receptors in the brain.

Diphenhydramine also acts as an intracellular sodium channel blocker, which is responsible for its actions as a local anesthetic.[38] Diphenhydramine has also been shown to inhibit the reuptake of serotonin.[39] It has been shown to be a potentiator of analgesia induced by morphine, but not by endogenous opioids, in rats.[40]

Pharmacokinetics[edit]

Oral bioavailability of diphenhydramine is in the range of 40–60% and peak plasma concentration occurs about 2–3 hours after administration.[1] The primary route of metabolism is two successive demethylations of the tertiary amine. The resulting primary amine is further oxidized to the carboxylic acid.[1] The half-life is as short as 8 hours in children to 17 hours in the elderly.[3]

History[edit]

Diphenhydramine was discovered in 1943 by George Rieveschl, a former professor at the University of Cincinnati.[41][42] In 1946, it became the first prescription antihistamine approved by the U.S. FDA.[43]

In the 1960s, diphenhydramine was found to inhibit reuptake of the neurotransmitter serotonin.[39] This discovery led to a search for viable antidepressants with similar structures and fewer side effects, culminating in the invention of fluoxetine (Prozac), a selective serotonin reuptake inhibitor (SSRI).[39][44] A similar search had previously led to the synthesis of the first SSRI, zimelidine, from brompheniramine, also an antihistamine.[45]

Society and culture[edit]

Diphenhydramine is sometimes used recreationally as a deliriant, or as a potentiator of alcohol,[46][47] opiates,[48] DXM and other depressants. Diphenhydramine is deemed to have limited abuse potential in the United States due to its potentially serious side-effect profile and limited euphoric effects, and is not a controlled substance. Since 2002, the U.S. FDA has required special labeling warning against use of multiple products that contain diphenhydramine.[49] In some jurisdictions, diphenhydramine is often present in postmortem specimens collected during investigation of sudden infant deaths; the drug may play a role in these events.[50][51]

Diphenhydramine is among prohibited and controlled substances in the Republic of Zambia,[52] and travelers are advised not to bring the drug into the country. Several Americans have been detained by the Zambian Drug Enforcement Commission for possession of Benadryl and other over-the-counter medications containing diphenhydramine.[53]

Recreational use[edit]

Diphenhydramine is sometimes used as a recreational drug, often by those without access to illegal drugs.[54] Recreational use of diphenhydramine may cause:[55]

  • Dysphoria
  • Hallucinations (auditory, visual, etc.)
  • Heart palpitations
  • Extreme drowsiness
  • Severe dizziness
  • Abnormal speech (inaudibility, forced speech, etc.)
  • Flushed skin
  • Severe mouth and throat dryness
  • Tremors
  • Seizures
  • Inability to urinate
  • Vomiting
  • Motor disturbances
  • Anxiety/nervousness
  • Disorientation
  • Abdominal pain
  • Delirium
  • Coma
  • Death

References[edit]

  1. ^ a b c Paton DM, Webster DR (1985). "Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines)". Clin. Pharmacokinet. 10 (6): 477–97. doi:10.2165/00003088-198510060-00002. PMID 2866055. 
  2. ^ "Showing Diphenhydramine (DB01075)". DrugBank. Retrieved 5 September 2009. 
  3. ^ a b c d Simons KJ, Watson WT, Martin TJ, Chen XY, Simons FE (July 1990). "Diphenhydramine: pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children". J. Clin. Pharmacol. 30 (7): 665–71. doi:10.1002/j.1552-4604.1990.tb01871.x. PMID 2391399. 
  4. ^ Garnett WR (February 1986). "Diphenhydramine". Am. Pharm. NS26 (2): 35–40. PMID 3962845. 
  5. ^ Ohio History central: Benadryl; accessed Jan. 5, 2011
  6. ^ "Diphenhydramine Hydrochloride Monograph". Drugs.com. The American Society of Health-System Pharmacists. 
  7. ^ Brown HE, Stoklosa J, Freudenreich O (December 2012). "How to stabilize an acutely psychotic patient" (PDF). Current Psychiatary. 11 (12): 10–16. 
  8. ^ Smith DW, Peterson MR, DeBerard SC (August 1999). "Local anesthesia. Topical application, local infiltration, and field block". Postgrad. Med. 106 (2): 57–60, 64–6. doi:10.3810/pgm.1999.08.650. PMID 10456039. 
  9. ^ a b American Society of Health-System Pharmacists. "Diphenhydramine Hydrochloride". Drugs.com. Retrieved 2 August 2016. 
  10. ^ a b Banerji, A; Long, AA; Camargo CA, Jr (2007). "Diphenhydramine versus nonsedating antihistamines for acute allergic reactions: a literature review.". Allergy and asthma proceedings : the official journal of regional and state allergy societies. 28 (4): 418–26. doi:10.2500/aap.2007.28.3015. PMID 17883909. 
  11. ^ Young WF (2011). "Chapter 11: Shock". In Roger L. Humphries RL; Stone CK. CURRENT Diagnosis and Treatment Emergency Medicine,. LANGE CURRENT Series (Seventh ed.). McGraw-Hill Professional. ISBN 0-07-170107-9. 
  12. ^ Sheikh, A; ten Broek, Vm; Brown, SG; Simons, FE (24 January 2007). "H1-antihistamines for the treatment of anaphylaxis with and without shock.". The Cochrane database of systematic reviews (1): CD006160. doi:10.1002/14651858.CD006160.pub2. PMID 17253584. 
  13. ^ MedlinePlus Encyclopedia Diphenhydramine Topical
  14. ^ Aminoff MJ (2012). "Chapter 28. Pharmacologic Management of Parkinsonism & Other Movement Disorders". In Katzung B, Masters S, Trevor A. Basic & Clinical Pharmacology (12th ed.). The McGraw-Hill Companies, Inc. pp. 483–500. ISBN 978-0-07-176401-8. 
  15. ^ Kristi Monson; Arthur Schoenstadt (8 September 2013). "Benadryl Addiction". eMedTV. 
  16. ^ Dinndorf PA, McCabe MA, Frierdich S (August 1998). "Risk of abuse of diphenhydramine in children and adolescents with chronic illnesses". J. Pediatr. 133 (2): 293–5. doi:10.1016/S0022-3476(98)70240-9. PMID 9709726. 
  17. ^ Zachary Flake; Robert Scalley; Austin Bailey (March 1, 2004). "Practical Selection of Antiemetics". American Family Physician. Retrieved March 10, 2016. 
  18. ^ "Diphenhydramine Side Effects". Drugs.com. Retrieved 6 April 2009. 
  19. ^ "Treating a Restless Legs Sydnrome (RLS)". Consumer Reports. 2011. 
  20. ^ a b c Brunton L, Chabner B, Knollmann B (2011). "Chapter 32. Histamine, Bradykinin, and Their Antagonists". In Brunton L. Goodman & Gilman's The Pharmacological Basis of Therapeutics (12e ed.). McGraw Hill. pp. 242–245. ISBN 978-0-07-162442-8. 
  21. ^ a b Manning B (2012). "Chapter 18. Antihistamines". In Olson K. Poisoning & Drug Overdose (6th ed.). McGraw-Hill. ISBN 978-0-07-166833-0. Retrieved 19 March 2013. 
  22. ^ "Block of potassium currents in guinea pig ventricular myocytes and lengthening of cardiac repolarization in man by the histamine H1 receptor antagonist diphenhydramine.". 
  23. ^ "Wide complex tachycardia in a pediatric diphenhydramine overdose treated with sodium bicarbonate.". Publisher Medical. Pediatr Emerg Care. Retrieved 25 November 2013. 
  24. ^ Heine A (November 1996). "Diphenhydramine: a forgotten allergen?". Contact Derm. 35 (5): 311–2. doi:10.1111/j.1600-0536.1996.tb02402.x. PMID 9007386. 
  25. ^ Coskey RJ (February 1983). "Contact dermatitis caused by diphenhydramine hydrochloride". J. Am. Acad. Dermatol. 8 (2): 204–6. doi:10.1016/S0190-9622(83)70024-1. PMID 6219138. 
  26. ^ a b de Leon J, Nikoloff DM (February 2008). "Paradoxical excitation on diphenhydramine may be associated with being a CYP2D6 ultrarapid metabolizer: three case reports". CNS Spectr. 13 (2): 133–5. PMID 18227744. 
  27. ^ Salahudeen MJ; Duffull SB; Nishtala PS; et al. (2015-03-25). "Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review". BMC Geriatrics. 15 (31). doi:10.1186/s12877-015-0029-9. PMC 4377853free to read. PMID 25879993. 
  28. ^ Medical Economics (2000). Physicians' Desk Reference for Nonprescription Drugs and Dietary Supplements, 2000 (21st ed.). Montvale, NJ: Medical Economics Company. ISBN 1-56363-341-8. 
  29. ^ "High risk medications as specified by NCQA's HEDIS Measure: Use of High Risk Medications in the Elderly" (pdf). National Committee for Quality Assurance (NCQA). 
  30. ^ "2012 AGS Beers List" (PDF). The American Geriatrics Society. Retrieved 27 November 2015. 
  31. ^ Black RA, Hill DA (June 2003). "Over-the-counter medications in pregnancy". Am. Fam. Physician. 67 (12): 2517–24. PMID 12825840. 
  32. ^ Spencer JP, Gonzalez LS, Barnhart DJ (July 2001). "Medications in the breast-feeding mother". Am. Fam. Physician. 64 (1): 119–26. PMID 11456429. 
  33. ^ American Academy of Hospice and Palliative Medicine, "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American Academy of Hospice and Palliative Medicine, retrieved 1 August 2013 , which cites
    • Smith TJ, Ritter JK, Poklis JL, Fletcher D, Coyne PJ, Dodson P, Parker G (2012). "ABH Gel is Not Absorbed from the Skin of Normal Volunteers". Journal of Pain and Symptom Management. 43 (5): 961–966. doi:10.1016/j.jpainsymman.2011.05.017. PMID 22560361. 
    • Weschules DJ (2005). "Tolerability of the Compound ABHR in Hospice Patients". Journal of Palliative Medicine. 8 (6): 1135–1143. doi:10.1089/jpm.2005.8.1135. PMID 16351526. 
  34. ^ a b c Pragst F (2007). "Chapter 13: High performance liquid chromatography in forensic toxicological analysis". In Smith RK, Bogusz MJ. Forensic Science (Handbook of Analytical Separations). 6 (2nd ed.). Amsterdam: Elsevier Science. p. 471. ISBN 978-0-444-52214-6. 
  35. ^ Rogers SC, Pruitt CW, Crouch DJ, Caravati EM (September 2010). "Rapid urine drug screens: diphenhydramine and methadone cross-reactivity". Pediatr. Emerg. Care. 26 (9): 665–6. doi:10.1097/PEC.0b013e3181f05443. PMID 20838187. 
  36. ^ a b Khilnani and Khilnani (Oct 2011). "Inverse agonism and its therapeutic significance". Indian J Pharmacol. 43 (5): 492–501. doi:10.4103/0253-7613.84947. PMC 3195115free to read. PMID 22021988. 
  37. ^ Lopez AM (10 May 2010). "Antihistamine Toxicity". Medscape Reference. WebMD LLC. 
  38. ^ Kim YS, Shin YK, Lee C, Song J (October 2000). "Block of sodium currents in rat dorsal root ganglion neurons by diphenhydramine". Brain Research. 881 (2): 190–8. doi:10.1016/S0006-8993(00)02860-2. PMID 11036158. 
  39. ^ a b c Domino EF (1999). "History of modern psychopharmacology: a personal view with an emphasis on antidepressants". Psychosom. Med. 61 (5): 591–8. doi:10.1097/00006842-199909000-00002. PMID 10511010. 
  40. ^ Carr KD, Hiller JM, Simon EJ (February 1985). "Diphenhydramine potentiates narcotic but not endogenous opioid analgesia". Neuropeptides. 5 (4–6): 411–4. doi:10.1016/0143-4179(85)90041-1. PMID 2860599. 
  41. ^ Hevesi D (29 September 2007). "George Rieveschl, 91, Allergy Reliever, Dies". The New York Times. Retrieved 14 October 2008. 
  42. ^ "Benadryl". Ohio History Central. Retrieved 13 August 2015. 
  43. ^ Ritchie J (24 September 2007). "UC prof, Benadryl inventor dies". Business Courier of Cincinnati. Retrieved 14 October 2008. 
  44. ^ Awdishn RA, Whitmill M, Coba V, Killu K (October 2008). "Serotonin reuptake inhibition by diphenhydramine and concomitant linezolid use can result in serotonin syndrome". Chest. 134 (4 Meeting abstracts). doi:10.1378/chest.134.4_MeetingAbstracts.c4002. 
  45. ^ Barondes SH (2003). Better Than Prozac. New York: Oxford University Press. pp. 39–40. ISBN 0-19-515130-5. 
  46. ^ "Diphenhydramine and Alcohol / Food Interactions". Drugs.com. 
  47. ^ Zimatkin SM, Anichtchik OV (1999). "Alcohol-histamine interactions". Alcohol Alcohol. 34 (2): 141–7. doi:10.1093/alcalc/34.2.141. PMID 10344773. 
  48. ^ Sandor I (30 July 2000). "Using Antihistamines, Anticholinergics, and Depressants To Potentiate Opiates, And Dealing With Opiate Side Effects". Antihistamine Aficionado Magazine. 
  49. ^ Food and Drug Administration, HHS (2002). "Labeling of Diphenhydramine-Containing Drug Products for Over-the-Counter Human Use". Federal Register. 67 (235): 72555–9. PMID 12474879. Retrieved 14 October 2008. 
  50. ^ Marinetti L, Lehman L, Casto B, Harshbarger K, Kubiczek P, Davis J (October 2005). "Over-the-counter cold medications-postmortem findings in infants and the relationship to cause of death". J. Anal. Toxicol. 29 (7): 738–43. doi:10.1093/jat/29.7.738. PMID 16419411. 
  51. ^ Baselt RC (2008). Disposition of Toxic Drugs and Chemicals in Man. Biomedical Publications. pp. 489–492. ISBN 0-9626523-7-7. 
  52. ^ "List of prohibited and controlled drugs according to chapter 96 of the laws of Zambia" (DOC). The Drug Enforcement Commission ZAMBIA. 
  53. ^ "Zambia". Country Information > Zambia. Bureau of Consular Affairs, U.S. Department of State. Retrieved 17 July 2015. 
  54. ^ Forest E (27 July 2008). "Atypical Drugs of Abuse". Articles & Interviews. Student Doctor Network. 
  55. ^ "Diphenhydramine overdose:". MedlinePlus Medical Encyclopedia. U.S. National Library of Medicine. 

Further reading[edit]

External links[edit]